Gavioli R - Search Results

1

Recent advances in the development of HIV-1 Tat-based vaccines.

Caputo A, Gavioli R, Ensoli B. Caputo A, et al. Among authors: gavioli r. Curr HIV Res. 2004 Oct;2(4):357-76. doi: 10.2174/1570162043350986. Curr HIV Res. 2004. PMID: 15544457 Review.

2

Immunization with low doses of HIV-1 tat DNA delivered by novel cationic block copolymers induces CTL responses against Tat.

Caputo A, Gavioli R, Altavilla G, Brocca-Cofano E, Boarini C, Betti M, Castaldello A, Lorenzini F, Micheletti F, Cafaro A, Sparnacci K, Laus M, Tondelli L, Ensoli B. Caputo A, et al. Among authors: gavioli r. Vaccine. 2003 Mar 7;21(11-12):1103-11. doi: 10.1016/s0264-410x(02)00555-8. Vaccine. 2003. PMID: 12559787

3

Novel biocompatible anionic polymeric microspheres for the delivery of the HIV-1 Tat protein for vaccine application.

Caputo A, Brocca-Cofano E, Castaldello A, De Michele R, Altavilla G, Marchisio M, Gavioli R, Rolen U, Chiarantini L, Cerasi A, Dominici S, Magnani M, Cafaro A, Sparnacci K, Laus M, Tondelli L, Ensoli B. Caputo A, et al. Among authors: gavioli r. Vaccine. 2004 Jul 29;22(21-22):2910-24. doi: 10.1016/j.vaccine.2003.12.025. Vaccine. 2004. PMID: 15246628

4

HIV-1 tat protein modulates the generation of cytotoxic T cell epitopes by modifying proteasome composition and enzymatic activity.

Gavioli R, Gallerani E, Fortini C, Fabris M, Bottoni A, Canella A, Bonaccorsi A, Marastoni M, Micheletti F, Cafaro A, Rimessi P, Caputo A, Ensoli B. Gavioli R, et al. J Immunol. 2004 Sep 15;173(6):3838-43. doi: 10.4049/jimmunol.173.6.3838. J Immunol. 2004. PMID: 15356131 Free article.

5

Vaccines based on the native HIV Tat protein and on the combination of Tat and the structural HIV protein variant DeltaV2 Env.

Ensoli B, Cafaro A, Caputo A, Fiorelli V, Ensoli F, Gavioli R, Ferrantelli F, Cara A, Titti F, Magnani M. Ensoli B, et al. Among authors: gavioli r. Microbes Infect. 2005 Nov;7(14):1392-9. doi: 10.1016/j.micinf.2005.07.016. Epub 2005 Sep 15. Microbes Infect. 2005. PMID: 16243561 Free article.

6

The Tat protein broadens T cell responses directed to the HIV-1 antigens Gag and Env: implications for the design of new vaccination strategies against AIDS.

Gavioli R, Cellini S, Castaldello A, Voltan R, Gallerani E, Gagliardoni F, Fortini C, Cofano EB, Triulzi C, Cafaro A, Srivastava I, Barnett S, Caputo A, Ensoli B. Gavioli R, et al. Vaccine. 2008 Jan 30;26(5):727-37. doi: 10.1016/j.vaccine.2007.11.040. Epub 2007 Dec 4. Vaccine. 2008. PMID: 18096278

7

HIV-1 Tat-based vaccines: an overview and perspectives in the field of HIV/AIDS vaccine development.

Caputo A, Gavioli R, Bellino S, Longo O, Tripiciano A, Francavilla V, Sgadari C, Paniccia G, Titti F, Cafaro A, Ferrantelli F, Monini P, Ensoli F, Ensoli B. Caputo A, et al. Among authors: gavioli r. Int Rev Immunol. 2009;28(5):285-334. doi: 10.1080/08830180903013026. Int Rev Immunol. 2009. PMID: 19811313 Review.

8

The HIV-1 Tat protein induces the activation of CD8+ T cells and affects in vivo the magnitude and kinetics of antiviral responses.

Nicoli F, Finessi V, Sicurella M, Rizzotto L, Gallerani E, Destro F, Cafaro A, Marconi P, Caputo A, Ensoli B, Gavioli R. Nicoli F, et al. Among authors: gavioli r. PLoS One. 2013 Nov 4;8(11):e77746. doi: 10.1371/journal.pone.0077746. eCollection 2013. PLoS One. 2013. PMID: 24223723 Free PMC article.

9

An attenuated herpes simplex virus type 1 (HSV1) encoding the HIV-1 Tat protein protects mice from a deadly mucosal HSV1 challenge.

Sicurella M, Nicoli F, Gallerani E, Volpi I, Berto E, Finessi V, Destro F, Manservigi R, Cafaro A, Ensoli B, Caputo A, Gavioli R, Marconi PC. Sicurella M, et al. Among authors: gavioli r. PLoS One. 2014 Jul 17;9(7):e100844. doi: 10.1371/journal.pone.0100844. eCollection 2014. PLoS One. 2014. PMID: 25033084 Free PMC article.

10

Effects of different routes of administration on the immunogenicity of the Tat protein and a Tat-derived peptide.

Finessi V, Nicoli F, Gallerani E, Sforza F, Sicurella M, Cafaro A, Caputo A, Ensoli B, Gavioli R. Finessi V, et al. Among authors: gavioli r. Hum Vaccin Immunother. 2015;11(6):1489-93. doi: 10.1080/21645515.2015.1016676. Hum Vaccin Immunother. 2015. PMID: 25875962 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

131 results

Search Page